Replies to post #24493 on Innovation Pharmaceuticals Inc (IPIX)

[Ovidius]

End the year in $4. to $5?! Wow, how expectations change and weaken!

I'll look for something more like Allan Harris's forecast of $13.00 a share and CTIX being his only right 'stock of the year' prediction that I know about. His track record on 'stock of the year' has been poor. But, I think he will be right with CTIX. See seeking alpha for his Dec 2012 CTIX prediction by Allan Harris.

I think 2013 will end with CTIX either in the $20.00s or ......!

[Gratefullife]

Nbd, but I popped that post out in three minutes in between clients, a minor expenditure of thought, erring towards conservatism and intended to bolster resolve.

A WHOLE lot more good could come of CTIX if either Prurisol or Kevetrin play out well.
In fact, I fully hope for an eventual buyout or partnership agreements, generating phenomenal gains.

My point was, even mixed results or delays will leave shareholders of just a few months ago in perfectly respectable positions by the end of year.

Kevetrin, as TOB pointed out in a sticky post above, need not be a miracle drug, it only has to help other drugs work in a fashion demonstrably superior to current therapies. It thus far appears to do so, garnering additional sponsored trials.

Prurisol could advance quite rapidly depending on results of our upcoming POC trial. My gut leans towards good outcomes on a variety of fronts.

[Brenum]

$4-$5?

I've seen everything now...

I've seen $5 predictions, I've seen $50 predictions, I've seen $150 dollar predictions.

Can anyone show some math on the matter? How much would the market for a cancer treating drug like Kevetrin amass?